Evidence map›Paper›PMID 20935161›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2010

Aryl hydrocarbon receptor nuclear translocator in hepatocytes is required for aryl hydrocarbon receptor-mediated adaptive and toxic responses in liver.

Manabu Nukaya, Jacqueline A Walisser, Susan M Moran, Gregory D Kennedy, Christopher A Bradfield

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Manabu NukayaMcArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53706, USA.
Jacqueline A Walisser
Susan M Moran
Gregory D Kennedy
Christopher A Bradfield
University of Wisconsin–Madison · USCenter for Cancer Research · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
Characterization of the Ah Receptor Signaling PathwayR37ES005703 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI BRADFIELD, CHRISTOPHER A · 2002 to 2011
$4.1M
TRANSGENIC MODELS OF DIOXIN ACTIONR01ES006883 · NIEHS · UNIVERSITY OF WISCONSIN MADISON · PI BRADFIELD, CHRISTOPHER A · 1994 to 2005
$1.8M
Genetic Insight Into AH Receptor-Mediated Promotion Of HepatocarcinogenesisK08ES017283 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI KENNEDY, GREGORY DEAN · 2009 to 2013
$777k
NCI NIH HHS P30-CA-014520NCI NIH HHS T32-CA-009135NIEHS NIH HHS K08-ES-017283NIEHS NIH HHS R01 ES006883NIEHS NIH HHS R01-ES-06883NIEHS NIH HHS R37-ES-05703
6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AHR) plays a central role in the toxic responses to halogenated dibenzo-p-dioxins ("dioxins"), in the metabolic adaptation to polycyclic aromatic hydrocarbons, and in the development of the mature vascular system. A number of lines of evidence support the idea that the regulation of adaptive metabolism requires an AHR partnership with the aryl hydrocarbon receptor nuclear translocator (ARNT). Yet, for AHR-dependent vascular development and dioxin toxicity, the role of ARNT is less certain. In fact, numerous models have been proposed over the years to suggest that the AHR signals in important ways via ARNT-independent events. In an effort to clarify the role of ARNT in AHR-mediated dioxin hepatotoxicity, we generated a conditional Arnt mouse model. Such a model was essential because global inactivation of Arnt results in embryonic lethality presumably due to this protein's role as a heterodimeric partner for the hypoxia-inducible factors (HIFs). Using a hepatocyte-specific Arnt deletion, we were able to demonstrate that hepatocyte ARNT is required for major aspects of AHR-mediated dioxin toxicity in the liver. Results from this conditional Arnt allele are also consistent with a model where hepatocyte ARNT is unrelated to AHR-mediated hepatovascular development. In sum, these data suggest that AHR-ARNT dimers within the hepatocyte direct the toxic and adaptive and developmental functions associated with the AHR and that developmental vascular events arise due to signaling in a distinct cell type expressing this dimeric pair.

Indexed as

Adaptation, PhysiologicalAnimalsAryl Hydrocarbon Receptor Nuclear TranslocatorChemical and Drug Induced Liver InjuryEnvironmental PollutantsGene DeletionGene ExpressionGene TargetingHepatocytesInjections, IntraperitonealLiverMaleMiceMice, Inbred C57BLMice, KnockoutPolychlorinated DibenzodioxinsArnt protein, mouseAryl Hydrocarbon Receptor Nuclear TranslocatorEnvironmental PollutantsPolychlorinated DibenzodioxinsReceptors, Aryl Hydrocarbon

Identifiers

PMID20935161
PMCPMC2984536
OpenAlexW2165796738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.